Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Invetx is raising $55,499,996.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jurgen Horn played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Invetx

At Invetx, we bring the best of biopharma to animal health. We are building the worlds premier animal health biotechnology innovation platform for protein-based therapeutics. Working closely with best-in-class biotechnology companies, major investors and an extensive network of industry experts, we are focused on guiding the development of an exciting portfolio of therapies and technologies to deliver the future of animal care. Our network includes experts in both animal and human health, veterinary scientists and clinicians. Our vision is of a global animal health industry that fully leverages biopharma technologies to deliver dramatically improved health outcomes for pets and farm animal populations.

To learn more about Invetx, visit http://www.invetx.com/

Contact:
Jurgen Horn, Chief Executive Officer
617-880-4592
jhorn@invetx.com
https://www.linkedin.com/in/juergen-horn-7930031/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved